Sotorasib is more cost-effective in treating patients with KRAS G12C non–small cell lung cancer (NSCLC) compared with adagrasib in second- and subsequent-line treatment, accordi ...
Home-based screening for anal cancer is a cost-effective way to increase screening compared to clinic-based screening, new ...
Introduction Many neonatal deaths are avoidable using existing low-cost evidence-based interventions. This study evaluated ...
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...
An updated analysis showed that LUPKYNIS is a cost-effective treatment for lupus nephritis, on par with other interventions for diabetes, blood pressure, and hyperlipidemia in adult patients with ...
Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...
Lifetime treatment with statins is a cost-effective therapy across a wide range of elderly patients with and without cardiovascular disease, according to an analysis published this week in Heart.
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Efanesoctocog alfa prophylaxis is conventionally cost-ineffective compared with standard factor VIII ...
Efanesoctocog alfa and standard-care factor VIII accrued 19.7 and 14.6 discounted lifetime quality-adjusted life years at costs of $22.1 and $11.2 million, respectively. HealthDay News — For US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback